Article info

Download PDFPDF

Research paper
Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis
Free

Authors

  1. Correspondence to Professor Helmut Butzkueven, L4 Centre, Melbourne Brain Centre at Royal Melbourne Hospital, Grattan St, Parkville, VIC 3050, Australia; butz{at}unimelb.edu.au
View Full Text

Citation

Lizak N, Lugaresi A, Alroughani R on behalf of the MSBase Study Group, et al
Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis

Publication history

  • Received May 12, 2016
  • Revised July 12, 2016
  • Accepted July 25, 2016
  • First published September 28, 2016.
Online issue publication 
February 17, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.